Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

JPMorgan Healthcare Conference 2013

Business Wire

WILMINGTON, Mass. -- January 7, 2013

Charles River Laboratories International, Inc. (NYSE: CRL) announced today
that it will present at the J.P. Morgan 31^st Annual Healthcare Conference in
San Francisco, California on Tuesday, January 8^th, at 10:00 a.m. PST
(1:00p.m. EST). Management will present an overview of Charles River’s
strategic focus and business developments.

A live webcast of the presentation will be available through a link that will
be posted on the Investor Relations section of the Charles River website at
ir.criver.com. A webcast replay will be accessible through the same website
approximately three hours after the presentation and will remain available for
approximately two weeks.

About Charles River

Accelerating Drug Development. Exactly. Charles River provides essential
products and services to help pharmaceutical and biotechnology companies,
government agencies and leading academic institutions around the globe
accelerate their research and drug development efforts. Our dedicated
employees are focused on providing clients with exactly what they need to
improve and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To learn more
about our unique portfolio and breadth of services, visit www.criver.com.

Contact:

Charles River Laboratories International, Inc.
Investor Relations Contact:
Susan E. Hardy, 781-222-6190
Corporate Vice President, Investor Relations
susan.hardy@crl.com
 
Press spacebar to pause and continue. Press esc to stop.